Stay updated on Pembrolizumab & Carboplatin in Metastatic Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab & Carboplatin in Metastatic Breast Cancer Clinical Trial page.

Latest updates to the Pembrolizumab & Carboplatin in Metastatic Breast Cancer Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedMinor backend version updates (from v3.2.0 to v3.3.2) with no changes to study content or user-facing functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check25 days agoChange DetectedDeletion of the site-wide notice about a lapse in government funding and NIH Clinical Center status; it does not affect the study content or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check46 days agoChange DetectedNo significant content changes detected; core study information remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check68 days agoChange DetectedCore content updated with a government-operating-status notice and a version upgrade to v3.2.0, replacing the previous v3.1.0.SummaryDifference3%

- Check75 days agoChange Detected- Updated revision from v3.0.2 to v3.1.0 - Added new contact details (phone numbers and email) for Massimo Cristofanilli and general supportSummaryDifference0.1%

- Check89 days agoChange DetectedBump from v3.0.1 to v3.0.2 and removal of the 'Back to Top' link; no significant changes to core content, pricing, stock, or time slots.SummaryDifference0.2%

Stay in the know with updates to Pembrolizumab & Carboplatin in Metastatic Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Carboplatin in Metastatic Breast Cancer Clinical Trial page.